ArticleOncogene2018

Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir-bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death.

Charlotte E Johnson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.